Prion diseases: Infectivity versus toxicity.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Do microbes have a memory? History-dependent behavior in the adaptation to variable environments.Frontiers in microbiology · 2022
   Review
2. The three faces of Sup35.Yeast (Chichester, England) · 2019
   Review
3. Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo.Molecular psychiatry · 2018
   Article
4. Yeast Short-Lived Actin-Associated Protein Forms a Metastable Prion in Response to Thermal Stress.Cell reports · 2017
   Article
5. Autophagic flux induced by graphene oxide has a neuroprotective effect against human prion protein fragments.International journal of nanomedicine · 2017
   Article
6. Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.Prion
   Article

Corrections and comments

• Comment on
  Prion propagation and toxicity in vivo occur in two distinct mechanistic phases.2011

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as